Novo Nordisk presents new Phase III data for next-gen amylin cagrilintide US$ 24.64 Min. order: 1 piece ★★★★★ 5.0 (121 reviews) Sold : Login>>
Novo Nordisk Aims for the Top: CagriSema Poised for Breakthrough US$ 22.88 Min. order: 1 piece ★★★★★ 4.2 (137 reviews) Sold : Login>>
Novo Nordisk's CagriSema trial deals blow in obesity drug battle with Eli Lilly US$ 21.95 Min. order: 1 piece ★★★★★ 4.1 (36 reviews) Sold : Login>>
Has anyone tried BCP-157 injections for MS? US$ 27.09 Min. order: 1 piece ★★★★★ 4.0 (268 reviews) Sold : Login>>
Novo Nosedives on Underwhelming CagriSema Phase III Weight-Loss Data US$ 25.70 Min. order: 1 piece ★★★★★ 4.9 (169 reviews) Sold : Login>>
Development of Cagrilintide, a Long-Acting Amylin Analogue US$ 28.84 Min. order: 1 piece ★★★★★ 4.6 (66 reviews) Sold : Login>>